A carregar...
Cost-utility analysis of imrecoxib compared with diclofenac for patients with osteoarthritis
BACKGROUND: To estimate the cost -utility of imrecoxib compared with diclofenac, as well as the addition of a proton pump inhibitor to both two treatment strategies, for patients with osteoarthritis, from a Chinese healthcare perspective. METHODS: A Markov model was built. Costs of managing osteoart...
Na minha lista:
| Publicado no: | Cost Eff Resour Alloc |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8056517/ https://ncbi.nlm.nih.gov/pubmed/33879168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-021-00275-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|